Bay Colony Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $552K | Sell |
1,240
-87
| -7% | -$38.7K | 0.08% | 229 |
|
|
2025
Q1 | $654K | Buy |
1,327
+275
| +26% | +$135K | 0.1% | 194 |
|
|
2024
Q4 | $424K | Sell |
1,052
-874
| -45% | -$352K | 0.06% | 272 |
|
|
2024
Q3 | $896K | Buy |
1,926
+87
| +5% | +$40.5K | 0.14% | 156 |
|
|
2024
Q2 | $862K | Buy |
1,839
+29
| +2% | +$13.6K | 0.14% | 141 |
|
|
2024
Q1 | $757K | Buy |
1,810
+954
| +111% | +$399K | 0.13% | 159 |
|
|
2023
Q4 | $348K | Buy |
856
+173
| +25% | +$70.4K | 0.07% | 254 |
|
|
2023
Q3 | $237K | Sell |
683
-39
| -5% | -$13.6K | 0.06% | 282 |
|
|
2023
Q2 | $254K | Sell |
722
-20
| -3% | -$7.04K | 0.06% | 268 |
|
|
2023
Q1 | $232K | Sell |
742
-2
| -0.3% | -$624 | 0.06% | 275 |
|
|
2022
Q4 | $215K | Buy |
+744
| New | +$215K | 0.06% | 315 |
|
|
2022
Q2 | – | Sell |
-1,612
| Closed | -$421K | – | 394 |
|
|
2022
Q1 | $421K | Sell |
1,612
-257
| -14% | -$67.1K | 0.1% | 198 |
|
|
2021
Q4 | $410K | Buy |
+1,869
| New | +$410K | 0.12% | 209 |
|